Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Technescan is a prominent brand of radiopharmaceutical cold kits used in nuclear medicine for diagnostic imaging. Originally developed by Mallinckrodt Pharmaceuticals, the Technescan product line is now owned and manufactured by Curium, a global leader in the radiopharmaceutical industry. The kits, such as Technescan MDP, MAG3, and PYP, are designed to be reconstituted with Technetium-99m to visualize specific organs or physiological processes, including bone metabolism, renal function, and myocardial infarction. These products are essential tools in nuclear medicine departments worldwide for a variety of diagnostic procedures. Curium maintains extensive manufacturing facilities to support the global supply of these critical diagnostic agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technescan.